These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


94 related items for PubMed ID: 2481029

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans.
    Kollins SH, Rush CR.
    Pharmacol Biochem Behav; 1999 Oct; 64(2):319-26. PubMed ID: 10515308
    [Abstract] [Full Text] [Related]

  • 43. Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure.
    Oliveto AH, Bickel WK, Kamien JB, Hughes JR, Higgins ST.
    Psychopharmacology (Berl); 1994 Apr; 114(3):417-23. PubMed ID: 7531852
    [Abstract] [Full Text] [Related]

  • 44. A comparison of the stimulus effects of codeine in rhesus monkeys under the contingencies of a two lever discrimination task and a cross self-administration paradigm: tests of generalization to pentazocine, buprenorphine, tilidine, and different doses of codeine.
    Hoffmeister F.
    Psychopharmacology (Berl); 1988 Apr; 94(3):315-20. PubMed ID: 3128807
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Discriminative stimulus effects of tramadol in humans.
    Duke AN, Bigelow GE, Lanier RK, Strain EC.
    J Pharmacol Exp Ther; 2011 Jul; 338(1):255-62. PubMed ID: 21467190
    [Abstract] [Full Text] [Related]

  • 47. Secobarbital and information processing.
    Rundell OH, Williams HL, Lester BK.
    Percept Mot Skills; 1978 Jun; 46(3 Pt 2):1255-64. PubMed ID: 683816
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Effect of d-amphetamine, secobarbital, and marijuana on choice behavior: social versus nonsocial options.
    Heishman SJ, Stitzer ML.
    Psychopharmacology (Berl); 1989 Jun; 99(2):156-62. PubMed ID: 2508149
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of alternative reinforcer magnitude and post-session drug supply.
    Greenwald MK, Steinmiller CL.
    Drug Alcohol Depend; 2009 Sep 01; 104(1-2):84-93. PubMed ID: 19464125
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Training dose: influences in opioid drug discrimination.
    Comer SD, France CP, Woods JH.
    NIDA Res Monogr; 1991 Sep 01; (116):145-61. PubMed ID: 1369665
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Methods for measuring the strength of discriminable drug effects.
    Overton DA, Leonard WR, Merkle DA.
    Neurosci Biobehav Rev; 1986 Sep 01; 10(3):251-63. PubMed ID: 3774245
    [Abstract] [Full Text] [Related]

  • 56. Effects of nefopam on visual tracking.
    Belleville JP, Dorey F, BEllville JW.
    Clin Pharmacol Ther; 1979 Oct 01; 26(4):457-63. PubMed ID: 487693
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. A procedure for studying the within-session onset of human drug discrimination.
    Silverman K, Mumford GK, Griffiths RR.
    J Exp Anal Behav; 1994 Mar 01; 61(2):181-9. PubMed ID: 8169567
    [Abstract] [Full Text] [Related]

  • 60. Physiological Testing of Drugs.
    Am J Dent Sci; 1898 Jun 01; 32(2):77-79. PubMed ID: 30750474
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.